Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Stem Cell Assay Market In The Coming Years?
In recent times, there has been substantial growth in the stem cell assay market size. It is projected to expand from a worth of $2.36 billion in 2024 to reach $2.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 20.5%. Factors such as advancements in biotechnology, progress in drug discovery and development, research in regenerative medicine, disease modeling, along with public and private investment have fueled the growth during the historical period.
In the coming years, the stem cell assay market is projected to experience dramatic growth, escalating to a valuation of $6.35 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 22.2%. The expansion prediction during the forecast period can be credited to contributing factors such as personalized medicine, cell therapy, organoid and tissue engineering, AI and machine learning, novel technologies, as well as regulatory and ethical issues. Foreseen trends during this anticipated growth period feature 3D cell culture models, high-throughput screening, personalised medicine, the use of CRISPR-Cas9 for genome editing, and drug safety and toxicity testing.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7701&type=smp
What Drivers Are Accelerating Expansion Of The Stem Cell Assay Market?
The rise in chronic diseases is anticipated to fuel the expansion of the stem cell assay market. Chronic diseases, defined as conditions or illnesses that typically persist for three months or more and have a likelihood of escalating in severity over time, can potentially be treated with stem cells. These cells aid in the creation of new antibodies and specialized cells effective in treating chronic diseases such as cancer. The World Cancer Research Fund International, a UK-based organization, reported in 2022 that the United Kingdom saw 50,700 lung cancer cases at a rate of 30.1 per 100,000 people. The year also witnessed the death of 16,855 women from lung cancer, reflecting a mortality rate of 17.4 per 100,000. Further, The Government of the United Kingdom stated in March 2024 that slightly more than 1,862,500 people in England, representing 3% of the population, had been diagnosed with coronary heart disease (CHD) by their GP in the fiscal year ending in 2023. Therefore, the escalating prevalence of chronic diseases is contributing to the growth of the stem cell assay market.
How Is The Global Stem Cell Assay Market Broken Down By Segment?
The stem cell assaymarket covered in this report is segmented –
1) By Type: Cell Viability And Toxicity Assays; Cell Apoptosis Assays; Cell Function Assays; Cell Identification Assays; Isolation And Purification Assays; Cell Differentiation Assay; Other Types
2) By Product: Instruments; Detection kit
3) By Application: Regenerative Medicine And Therapy Development; Drug Discovery And Development; Clinical Research
4) By End User: Government Research Institutes; Private Research Institutes; Industry Research
Subsegments:
1) By Cell Viability and Toxicity Assays: MTT Assay; Resazurin Assay; ATP Assay; LDH Release Assay
2) By Cell Apoptosis Assays: Caspase Activity Assays; Annexin V Staining Assays; TUNEL Assay; Cell Death Detection Assays
3) By Cell Function Assays: Proliferation Assays; Migration and Invasion Assays; Differentiation Assays
4) By Cell Identification Assays: Flow Cytometry-Based Assays; Surface Marker Characterization; Immunocytochemistry Assays
5) By Isolation and Purification Assays: Magnetic-Activated Cell Sorting (MACS); Fluorescence-Activated Cell Sorting (FACS); Density Gradient Centrifugation
6) By Cell Differentiation Assay: Lineage-Specific Differentiation Assays; Gene Expression Analysis During Differentiation
7) By Other Types: 3D Culture Assays; High-Content Screening Assays; Biomarker Discovery Assays
Which Market Trends Are Expected To Define The Future Of The Stem Cell Assay Market?
Innovations in products are emerging as significant trends in the stem cell assay market. Many major market players are launching novel products to retain their market position. For instance, in May 2022, Beckman Coulter Life Sciences, a healthcare company based in the US, unveiled the AQUOS STEM System, designed to assist in the cultivation of hematopoietic stem cells. The system significantly reduces manual involvement by 95% via an automatized modular procedure, errors are trimmed down by 87.5%, and it contributes to time efficiency. The AQUIOS CL Flow Cytometer, which combines sample preparation and examination in a single compact platform, powers this system.
Which Firms Are Making The Biggest Impact In The Stem Cell Assay Market?
Major companies operating in the stem cell assay market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report
Which Geographic Regions Are Creating Strong Demand In The Stem Cell Assay Market?
North America was the largest region in the stem cell assay market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell assay market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7701&type=smp
Browse Through More Reports Similar to the Global Stem Cell Assay Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model